Patents by Inventor Timothy J. Jegla

Timothy J. Jegla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020182691
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of CNG2B, antibodies to CNG2B, methods of detecting CNG2B, and methods of screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG2B. The invention further provides, in a computer system, a method of screening for mutations of human CNG2B genes as well as a method for identifying a three-dimensional structure of human CNG2B polypeptides.
    Type: Application
    Filed: August 10, 2001
    Publication date: December 5, 2002
    Applicant: ICAgen, Inc.
    Inventors: Christopher D. Creech, Timothy J. Jegla
  • Patent number: 6432645
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of BK beta 2, BK beta 3, and BK beta 4, antibodies to the BK beta subunits, methods of detecting the BK beta subunits, methods of screening for modulators of Slo potassium channels comprising BK beta subunits, and kits for screening for activators and inhibitors of the Slo family potassium channels comprising BK beta subunits.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: August 13, 2002
    Assignee: ICAgen Inc.
    Inventors: Timothy J. Jegla, Alan Wickenden, Yi Liu
  • Publication number: 20020102677
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of KCNQ5, antibodies to KCNQ5, methods of detecting KCNQ5, methods of screening for potassium channel activators and inhibitors using biologically active KCNQ5, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising KCNQ5.
    Type: Application
    Filed: March 15, 2001
    Publication date: August 1, 2002
    Inventor: Timothy J. Jegla
  • Patent number: 6413741
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of hElk, antibodies to hElk, methods of detecting hElk, methods of screening for voltage-gated potassium channel activators and inhibitors using biologically active hElk, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising hElk.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: July 2, 2002
    Assignee: ICAgen, Incorporated
    Inventors: Timothy J. Jegla, Alan Wickenden